Enhancing Scalability: Reducing Manual Burden in Adherent Cell Production for Cell Therapy with the Ascent Fixed Bed Bioreactor
Time: 3:00 pm
day: Day One Track B PM
Details:
- Cell therapy is at an inflection point where scale-up specific to cell therapy is necessary for translation of drug products to the clinic
- The Ascent fixed bed bioreactor is a bioreactor system that addresses cell therapy-specific process requirements, allowing for production of large lots of Hemangioblast-derived mesenchymal cells (HMCs)
- Both expansion and mitochondrial inactivation of human dermal fibroblasts can be done in a single Ascent bioreactor system, which greatly increases lot sizes, and reduces person hours
